Navigation Links
33rd ESMO Congress in Stockholm, 12-16 September 2008

LUGANO, Switzerland, September 5 /PRNewswire/ -- The 33rd ESMO Congress in Stockholm, the premier European congress in Oncology, serves as a meeting place for medical oncologists, as well as a focal point to exchange ideas with colleagues from other disciplines.

The Congress Centre will be the venue for interdisciplinary interaction, a teaching ground, and a place to discuss critical issues for European oncology such as cancer research in Europe, the training of young oncologists and better integration of medical oncology with other specialties and patient advocacy groups.

Highlights of Congress Program:

Please respect individual embargo dates/times

Access to drugs

European disparities in access to cancer drugs

(Embargoed until Monday, 15 September 2008, 12:30 CEST)

New research has highlighted stark disparities in access to the latest cancer drugs across European Union nations. Dr. Nils Wilking from the Karolinska Institute in Stockholm gathered data on the sales of newer drugs per inhabitant of each country provided by pharmaceutical industry consultants IMS Health. His group's focus was on the uptake of newer 'targeted' drugs over the past 10 years in 27 countries.

Lung Cancer

Significant benefits in non-small-cell lung cancer from customising


(Embargoed until Saturday 13 September 2008, 12:45 CEST)

Lung cancer patients whose tumours carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report. Investigators from the Spanish Lung Cancer Group conducted the largest-ever study to examine the benefits of customising lung cancer treatment based on mutations in the epidermal growth factor receptor (EGFR) gene.

Phase II trial of pazopanib before surgery in early lung cancer

(Embargoed until Monday, 15 September 2008, 10:45 CEST)


SOURCE ESMO European Society for Medical Oncology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
4. Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa
5. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
6. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
7. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
8. Bruker Announces Availability of New HUPO World Congress Proteomics Posters on Web Site
9. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. The Library of Congress in your wrist watch?
Post Your Comments:
(Date:8/19/2014)... One of the major limitations in ... vascular supply. Nutrient and gas transport throughout synthetic ... for successful regeneration and integration into the patient’s ... vascularization and promote angiogenesis in a variety of ... and architecture, and enhancing scaffolds with stem cells. ...
(Date:8/19/2014)... (PRWEB) August 19, 2014 ... to raise $200,000 to fund a corporate lab ... , This development is a critical component ... of care to the implementation of personalized medicine ... of practicing medicine. , Indiegogo contributions will support ...
(Date:8/19/2014)... 2014 Research and Markets ... "Spectroscopy Equipment and Accessories - Global ... offering. This report analyzes ... Accessories in US$ Thousands by the following ... Spectrometers, NMR-EPR Spectrometers, Near Infrared (NIR) Spectrometers, ...
(Date:8/19/2014)... - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ... Oral Amphotericin B (Oral Amp B) drug candidate ... ImmuneCarta®, the immune monitoring business unit of Caprion, ... Amp B in reactivating latent HIV viral reservoirs ... with antiretroviral therapy. Memory cells, ...
Breaking Biology Technology:Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3
... approves Intercell,s first marketed product, a new vaccine against ... product launch in the U.S. planned for Q2 2009VIENNA, ... that the U.S. Food and Drug Administration (FDA) approved ... Encephalitis (JE). The initial target for use of Intercell,s ...
... Mylan Inc. (Nasdaq: MYL ) today ... which it holds a 71.2% controlling interest, has received ... Drug Administration (FDA) under the President,s Emergency Plan for ... (ANDA) for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 ...
... WALTHAM, Mass., March 30 Inverness Medical Innovations, Inc. (NYSE: ... to take charge of their health at home through the ... dividend of $3.00 per share on its Series B Convertible ... in shares of Series B stock in an amount per ...
Cached Biology Technology:Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 2Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 3Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 4Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R) 2
(Date:8/20/2014)... at Huntsman Cancer Institute (HCI) at the University of ... gene that encodes BCR-ABL, the unregulated enzyme driving the ... American Cancer Society, nearly 6,000 new cases of CML ... use, called tyrosine kinase inhibitors (TKIs), target BCR-ABL and ... cure CML but control it in a way that ...
(Date:8/20/2014)... fires are visible in in this image of the ... of these were most likely intentionally set in order ... a forest or stand of trees where the land ... deforestation include conversion of forestland to farms, ranches, or ... dark green of the Amazon Rainforest in the middle ...
(Date:8/20/2014)... Research UK scientists have discovered that acral melanomas the ... Marley,s death are genetically distinct from other more common ... external) published in the journal Pigment Cell & Melanoma ... of the hands, soles of the feet, nail-beds and other ... of melanoma, it,s not caused by UV damage from the ...
Breaking Biology News(10 mins):Blueprint for next generation of chronic myeloid leukemia treatment 2Scientists learn more about rare skin cancer that killed Bob Marley 2
... Increasing block-rate water budgets are an innovative type ... block sizes are based on household characteristics, environmental conditions, ... to what constitutes "efficient" water use given those characteristics ... set relatively low for the most essential uses of ...
... the most serious are poverty, the growing demand for ... to satisfy the growing demand for wood, forestry in ... the Russian Federation are the world,s largest reserve of ... will result in increasing availability of wood for material ...
... of data related to climate change are being compiled ... these many and various sources results in different climate ... data sets to arrive at a consensus regarding future ... December in the SIAM Journal on Uncertainty Quantification ...
Cached Biology News:An innovative approach to promote water use efficiency 2An innovative approach to promote water use efficiency 3Sustainable use of energy wood resources shows potential in North-West Russia 2Sustainable use of energy wood resources shows potential in North-West Russia 3Statistics research could build consensus around climate predictions 2Statistics research could build consensus around climate predictions 3Statistics research could build consensus around climate predictions 4
... Kit is intended for quantitative detection of ... which can result from the gradual, nonenzymatic ... acid residues during storage or handling. Because ... monitoring of charge differences for detection, charge ...
... siRNA and miRNA Isolation Traditional mRNA ... mRNA and can result in the loss ... mirVana miRNA Isolation Kit purifies all RNA ... double-stranded. Through an enrichment procedure included in ...
ABI Plant AFLP Kits • EcoRI-ACA AFLP Amplification Primers...
Biology Products: